InnoCan Pharma Corporation (CSE:INNO)
Canada
· Delayed Price · Currency is CAD 0.1700
-0.0100 (-5.56%)
Apr 24, 2025, 9:30 AM EDT
InnoCan Pharma Revenue
In the year 2024, InnoCan Pharma had annual revenue of $29.44M USD with 115.55% growth. InnoCan Pharma had revenue of $5.40M in the quarter ending December 31, 2024, with 10.38% growth.
Revenue
$29.44M
Revenue Growth
+115.55%
P/S Ratio
1.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
52.64M CAD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 893.16M |
| Extendicare | 1.47B |
| Trulieve Cannabis | 1.71B |
| WELL Health Technologies | 919.69M |
| Cronos Group | 169.23M |
| Curaleaf Holdings | 1.93B |